Moderna (MRNA) Return on Invested Capital Growth (3y) (2023 - 2026)

Moderna (MRNA) Return on Invested Capital Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 2.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 3.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Moderna 21.94 Bn 16.73 Bn -566.00 Mn -17.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.00
Dec 31, 2025 -16.00
Sep 30, 2025 -10.00
Jun 30, 2025 -8.00
Mar 31, 2025 -9.00
Dec 31, 2024 -10.00
Sep 30, 2024 -8.00
Jun 30, 2024 -7.00
Mar 31, 2024 -3.00
Dec 31, 2023 1.00
Sep 30, 2023 2.00
Jun 30, 2023 5.00
Mar 31, 2023 10.00